Marex Group Limited MRX 深 滬
已收盤 07-02 16:00:00 美东时间
62.52
-2.700
-4.14%
華盛通- 最 高66.60
- 今 開65.47
- 成交量 91.44万股
- 最 低 61.90
- 昨 收 65.22
- 總市值 449.71万
- 52周最高 67.35
- 市盈率 靜 16.19
- 換手率 1271.23%
- 52周最低 27.45
- 委 比 61.94%
- 總股本 7.19万
- 歷史最高 67.35
- 量 比 0.64
- 振 幅 7.21%
- 歷史最低 16.95
- 每 手 1
- 風險率 9.21%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Marex redomiciliation to Bermuda: Scheme becomes effective
Marex Group Limited has completed its redomiciliation from England and Wales to Bermuda, effective July 1, 2026. Shareholders approved the move in May 2026, followed by regulatory approvals and court sanction. CEO Ian Lowitt stated the move simplifies the company's structure, improves efficiency, and aligns with its Nasdaq listing under Bermuda's US-style corporate law.
07-01 11:07
Marex-backed Winterflood says SpaceX IPO draws nearly $1 billion in UK retail demand via POP regime
Marex-backed Winterflood says SpaceX IPO draws nearly $1 billion in UK retail demand via POP regime Marex management outlined how Winterflood enabled UK retail participation in SpaceX’s IPO via the Public Offer Platform regime and the WRAP platform. UK retail demand reached about USD 1 billion from
06-18 17:18
Marex Group plc Announces Closing of U.S.$500 Million Hybrid Notes
Marex Group completed a $500 million offering of perpetual subordinated resettable fixed rate notes. Proceeds will be used for general corporate purposes, including repurchasing existing $100 million 13.250% notes and funding acquisitions. CEO Ian Lowitt highlighted the successful issuance at a lower pricing of 7.7% compared to previous offerings, reflecting improved business strength. The offering was supported by strong investor participation, ...
06-09 20:05
美股大行评级 | 存储再获看多！美光、闪迪、西部数据获机构上调目标价；次新股Cerebras、Blackstone、EagleRock获多家机构首予买入平均
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5.25美元升至5.5美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9美元升至9.25美元
06-09 11:33
TD Cowen Maintains Buy on Marex Group, Raises Price Target to $75
TD Cowen analyst Bill Katz maintains Marex Group (NASDAQ:MRX) with a Buy and raises the price target from $67 to $75.
06-08 22:59
Marex appoints Georges Assi to the Group Board
Marex Group plc has appointed Georges Assi to its Board, effective immediately, where he will serve on the Risk Committee. Assi, a fintech entrepreneur with extensive experience in investment banking, is CEO of Sigma Lending and Co-Founder of Naviter Capital. He previously held senior roles at Nomura International and Lehman Brothers. Marex Chair Robert Pickering highlighted Assi's entrepreneurial success, fintech expertise, and investment bankin...
06-08 13:00
Marex acquires liquidity provider Levmet
Marex Group (MRX) on Monday announced the acquisition of Levmet, a liquidity provider in physical and derivatives markets across base metals, ferrous metals, energy, and power. Terms of the deal were...
06-01 19:23
Marex Group Acquires Levmet To Expand Its Physical Market-Making Operations And Adding Capabilities In European Power And Gas Trading, Financial Terms Not Disclosed
Headquartered in Monaco, Levmet is a liquidity provider in both physical and derivatives markets across base metals, ferrous metals, energy and power. Acquiring Levmet adds new capabilities to Marex with which it
06-01 19:05
Marex Group plc acquires Levmet
Marex Group has acquired Levmet, enhancing its physical market making operations and adding expertise in European power and gas trading. Levmet, based in Monaco, provides liquidity in base metals, ferrous metals, energy, and power. The acquisition aligns with Marex's strategy to diversify its services and earnings. Marex President Simon van den Born highlighted Levmet's strong risk management and the opportunities for growth. Levmet CEO Andrew Ca...
06-01 11:00
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
